US$ 28.97
glp 1 under $200 That $200/month GLP-1 from a telehealth app? It is probably compounded semaglutide. Not FDA-approved. Not the same drug. No in-person exam. No bloodwork. No follow-up if something goes wrong. CityHealth prescribes FDA-approved with many recommending combining the supplement with healthy eating and hydration for optimal effects MyGLP-1™ ProClinical Support – Purity
Description
PubMed,

Novo Nordisk has launched its own telehealth programme for regular-dose semaglutide through its own channels, as well as other providers, for $499 per month, although a partnership with Hims & Hers quickly broke down due to what the company said were "concerns about [] illegal mass compounding and deceptive marketing." Hims & Hers which accused Novo Nordisk of 'anticompetitive' actions is now offering a compounded version at $199 per month.

Tirzepatide remains active for days, so shifting your injection by a few hours or even a day has minimal impact

Tirzepatide and other GLP-1/GIP medications are prescription treatments that require medical supervision

The global GLP-1 analogues market size was calculated at USD 66.48 billion in 2025 and is predicted to increase from USD 88.58 billion in 2026 to approximately USD 1,062.90 billion by 2035, expanding at a CAGR of 31.94% from 2026 to 2035
